Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) Terminated Phase 2 Trials for Midostaurin (DB06595)

Also known as: Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)

IndicationStatusPhase
DBCOND0036073 (Adult Acute Myeloid Leukemia With T(8;21)(q22;q22))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01846624Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment